Gilles A. Robichaud - Concepedia

Author

Gilles A. Robichaud

Also Known As

G Robichaud, G. A. Robichaud, G.A. Robichaud, GILLES A. ROBICHAUD, Gilles A Robichaud, Gilles A. Robichaud, Gilles Andre Robichaud, Gilles Robichaud, Robichaud, Gilles A.

107

Publications

1.1K

Citations

H-Index

Concepts

All Affiliations

Université de Moncton Atlantic Cancer Research Institute Centre hospitalier universitaire de Québec Université Laval University of New Brunswick

About

Gilles A. Robichaud is an author at Université de Moncton specializing in medicine, cell biology, and tumor biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	12	422
2	Natural Sciences	2	2	29
3	Engineering	1	1	13
4	Health Sciences	1	1	12
5	Biochemistry	1	1	16

Gilles A. Robichaud

Publications

825

Citations

H-Index

Page 1

	Year	Citations
Synthesis and structure–activity relationship of 1- and 2-substituted-1,2,3-triazole letrozole-based analogues as aromatase inhibitors Jérémie A. Doiron, Al Halifa Soultan, Ryan Richard, European Journal of Medicinal Chemistry Structure–activity RelationshipMedicinal ChemistryDiversity Oriented SynthesisMedicineOrganic Chemistry	2011	85
Anti-mycobacterial natural products from the Canadian medicinal plant Juniperus communis Caitlyn D. Carpenter, Taryn O’Neill, Nadia Picot, Journal of Ethnopharmacology MedicineHerbal MedicineAntibacterial AgentPhytochemicalMicrobiology	2012	78
HIV-1 Transcription and Virus Production Are Both Accentuated by the Proinflammatory Myeloid-Related Proteins in Human CD4+ T Lymphocytes Carle Ryckman, Gilles A. Robichaud, Jocelyn Roy, The Journal of Immunology Hiv-1 TranscriptionMrp-mediated InductionAutoimmune DiseaseHuman RetrovirusImmunology	2002	56
Deoxypodophyllotoxin Isolated from Juniperus communis Induces Apoptosis in Breast Cancer Cells Sami Benzina, Jason Harquail, Stéphanie Jean, Anti-Cancer Agents in Medicinal Chemistry	2014	50
Human Pax-5 C-terminal Isoforms Possess Distinct Transactivation Properties and Are Differentially Modulated in Normal and Malignant B Cells Gilles A. Robichaud, M. Nardini, Mark Laflamme, Journal of Biological Chemistry	2004	45
Nuclear Factor of Activated T Cells Is a Driving Force for Preferential Productive HIV-1 Infection of CD45RO-expressing CD4+ T Cells Gilles A. Robichaud, Benoı̂t Barbeau, Jean-François Fortin, Journal of Biological Chemistry Activated T CellsNuclear FactorProductive Hiv-1 ReplicationHuman RetrovirusT-regulatory Cell	2002	38
Regulation of nuclear factor of activated T cells by phosphotyrosyl-specific phosphatase activity: a positive effect on HIV-1 long terminal repeat–driven transcription and a possible implication of SHP-1 Jean-François Fortin, Benoı̂t Barbeau, Gilles A. Robichaud, Blood	2001	38
Pax-5 is a potent regulator of E-cadherin and breast cancer malignant processes Sami Benzina, Annie‐Pier Beauregard, Roxann Guérrette, Oncotarget Breast OncologyPotent RegulatorEndocrine-related CancerMedicineImmunology	2017	34
CAPE Analogs Induce Growth Arrest and Apoptosis in Breast Cancer Cells Annie‐Pier Beauregard, Jason Harquail, Grégoire Lassalle-Claux, Molecules Cape AnalogsBreast OncologyChemoprevention StrategyMedicineApoptosis	2015	33
Intracellular Expression of Inflammatory Proteins S100A8 and S100A9 Leads to Epithelial-mesenchymal Transition and Attenuated Aggressivity of Breast Cancer Cells Kévin Cormier, Jason Harquail, Rodney J. Ouellette, Anti-Cancer Agents in Medicinal Chemistry	2014	32

Page 1